These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 19056798

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
    Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, Denton CP.
    Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
    [Abstract] [Full Text] [Related]

  • 4. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP, Diot E, Clerson P, Dupuis-Siméon F, Hachulla E, Hatron PY, Constans J, Cirstéa D, Farge-Bancel D, Carpentier PH.
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [Abstract] [Full Text] [Related]

  • 5. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Gallego-Villalobos M, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban Marcos EM, Pallarés-Ferreres L, Hidalgo-Tenorio C, Sabio-Sánchez JM, Gómez-de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Gil-Aguado A, Vilardell-Tarrés M.
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, Black CM.
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [Abstract] [Full Text] [Related]

  • 9. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
    Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP.
    QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
    [Abstract] [Full Text] [Related]

  • 10. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
    Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, Medsger TA.
    J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
    [Abstract] [Full Text] [Related]

  • 11. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A, Bartosik I, Wuttge DM, Hesselstrand R.
    Scand J Rheumatol; 2009 Apr; 38(4):295-8. PubMed ID: 19214870
    [Abstract] [Full Text] [Related]

  • 12. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S, Fujimoto M, Hasegawa M, Komura K, Yanaba K, Hayakawa I, Matsushita T, Takehara K.
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [Abstract] [Full Text] [Related]

  • 13. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD, Medsger TA.
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [Abstract] [Full Text] [Related]

  • 14. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.
    Nihtyanova SI, Brough GM, Black CM, Denton CP.
    Ann Rheum Dis; 2008 Jan; 67(1):120-3. PubMed ID: 17660220
    [Abstract] [Full Text] [Related]

  • 15. Skin involvement in scleroderma--where histological and clinical scores meet.
    Verrecchia F, Laboureau J, Verola O, Roos N, Porcher R, Bruneval P, Ertault M, Tiev K, Michel L, Mauviel A, Farge D.
    Rheumatology (Oxford); 2007 May; 46(5):833-41. PubMed ID: 17255134
    [Abstract] [Full Text] [Related]

  • 16. Mandibular function is severely impaired in systemic sclerosis patients.
    Ferreira EL, Christmann RB, Borba EF, Borges CT, Siqueira JT, Bonfa E.
    J Orofac Pain; 2010 May; 24(2):197-202. PubMed ID: 20401358
    [Abstract] [Full Text] [Related]

  • 17. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.
    Maurer B, Graf N, Michel BA, Müller-Ladner U, Czirják L, Denton CP, Tyndall A, Metzig C, Lanius V, Khanna D, Distler O, EUSTAR co-authors.
    Ann Rheum Dis; 2015 Jun; 74(6):1124-31. PubMed ID: 24981642
    [Abstract] [Full Text] [Related]

  • 18. A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis.
    Sandqvist G, Hesselstrand R, Eberhardt K.
    Scand J Rheumatol; 2009 Jun; 38(4):304-10. PubMed ID: 19296402
    [Abstract] [Full Text] [Related]

  • 19. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.
    Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP.
    Rheumatology (Oxford); 2005 Dec; 44(12):1518-24. PubMed ID: 16159952
    [Abstract] [Full Text] [Related]

  • 20. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.